Dobutamine Injection 250 mg/20 mL (12.5 mg/mL) Single-Dose Vial, Sterile Solution 20 mL (Rx)

Dobutamine Injection

Dobutamine Injection by Slate Run Pharmaceuticals delivers life-saving, rapid-acting support to patients in need of improved cardiac output, with a highly concentrated and sterile 12.5 mg/mL formulation. Each 20 mL single-dose vial contains 250 mg of dobutamine—the trusted first-line inotropic agent for acute decompensated heart failure and cardiac stress testing. This FDA-approved, hospital-grade solution is designed for IV administration by healthcare professionals for critically ill patients.

Key Benefits & Uses

• Acute Inotropic Support Rapidly increases cardiac contractility and stroke volume, improving cardiac output for patients with heart failure or cardiogenic shock.
• Short-Term Heart Failure Management Essential for acute decompensated heart failure and severe circulatory compromise where immediate hemodynamic support is required.
• Cardiac Stress Testing Used as a pharmacologic agent during dobutamine stress echocardiography for coronary artery disease diagnosis when exercise is not possible.
• Post-Cardiac Surgery Stabilization Supports myocardial function in the critical post-op phase for cardiac surgery or transplantation.
• Precision, Sterile, Ready-to-Use 20 mL single-dose vial ensures quick, accurate IV dosing in emergency and ICU settings.

What Dobutamine Injection is Used For

• Acute treatment of heart failure with reduced cardiac output
• Short-term management of cardiac decompensation due to organic heart disease or surgery
• Hemodynamic support in cardiogenic shock, septic shock, and post-surgical low-output states
• Adjunct in cardiac imaging for myocardial perfusion stress testing

Who Needs Dobutamine Injection?

• Hospitalized patients with acute decompensated heart failure
• Patients in cardiogenic shock or experiencing severe low cardiac output
• Postoperative cardiac surgery patients requiring inotropic support
• Patients undergoing dobutamine stress echocardiography
• Critical care and intensive care unit (ICU) settings
• Cardiologists, ICU/CCU physicians, emergency and anesthesia teams

Health Category

• Cardiovascular Drugs (Rx)
• Acute & Critical Care Medications
• Heart Failure and Shock Management
• Inotropic Agents
• Advanced Cardiac Life Support (ACLS)
• Cardiology & Emergency Medicine

Related Prescription Products

• Milrinone Lactate Injection
• Dopamine Hydrochloride Injection
• Epinephrine Injection (Adrenaline)
• Norepinephrine Bitartrate Injection
• Nitroglycerin IV
• Isoproterenol HCl Injection
• Vasopressin Injection
• Levosimendan (outside US)
• Nitroprusside Sodium Injection

Product Number: 7043620380 | NDC: 70436-0203-80

Directions for Administration

• FOR INTRAVENOUS ADMINISTRATION ONLY.
• Dosage should be individualized based on clinical response. Infusion is typically initiated at 2-20 mcg/kg/min and titrated per cardiac output and blood pressure goals.
• Administer in a clinical setting under continuous cardiac monitoring by qualified healthcare professionals.
• Refer to full prescribing information for detailed dosage, dilution, and compatibility data.

Side Effects

Dobutamine is generally well-tolerated when used as directed under professional supervision. Possible side effects may include:

• Increased heart rate (tachycardia)
• Arrhythmias (atrial or ventricular)
• Elevated blood pressure or hypotension
• Chest pain or palpitations
• Nausea, headache, or mild tremor
• Local injection site reactions (rare)
• Serious: Severe arrhythmias, myocardial ischemia, hypertensive crisis, allergic reactions

Caution: Intensive monitoring required. Not for use in patients with idiopathic hypertrophic subaortic stenosis. Avoid extravasation; use with caution in patients with atrial fibrillation or underlying cardiac arrhythmias.

Why Choose Dobutamine Injection by Slate Run Pharmaceuticals?

• Highest purity, FDA-approved sterile formulation
• Trusted in hospital ICUs, ERs, and operating suites nationwide
• Rapid, consistent increase in cardiac contractility and output
• Precise 12.5 mg/mL strength for flexible dosing
• Reliable single-dose vials for easy, safe handling and administration

Save lives and restore vital cardiac function with Dobutamine Injection 250 mg/20 mL (12.5 mg/mL) by Slate Run Pharmaceuticals—your essential inotrope for advanced cardiac and critical care.

Product Number: 7043620380 | NDC: 70436-0203-80

Order today for your hospital, emergency department, or cardiology practice—for fast, dependable cardiac support in every critical moment.